allosteric MALT1 protease (paracaspase) inh.

oral QD act. in xenograft; on-target pathology

from 1M cmpd biochem. HTS and opt.

J. Med. Chem., Nov. 20, 2020

Novartis, Basel, CH

Chemical structure of the MLT-985 (Novartis allosteric MALT1 protease inhibitor)

MLT-985 (Novartis allosteric MALT1 protease (paracaspase) inhibitor)

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: